Wang & Lee Group board approves 250-to-1 reverse share split
Investing.com -- Ginkgo Bioworks Holdings (NYSE:DNA) stock climbed 3.8% following the announcement of a new collaboration with Hugging Face to open up high-quality biological datasets for machine learning applications.
The partnership aims to make biological data more accessible to the artificial intelligence community, potentially accelerating drug development processes. Georgia Channing from Hugging Face revealed on X that the companies have released the GDPx and GDPa dataset series on their Hub, which she described as providing a "x1000 boost to AI for drug development."
This collaboration represents a significant step in applying machine learning to biological research, as it provides AI researchers with access to specialized datasets that could help advance drug discovery efforts. Ginkgo Bioworks, known for its work in synthetic biology, continues to expand its technological capabilities through strategic partnerships.
The market’s positive reaction suggests investors see potential value in the intersection of synthetic biology and artificial intelligence, particularly for applications in pharmaceutical development.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.